NRAS and colonic neoplasm: Nelfinavir also sensitized NRAS mutant melanoma cells to MEK inhibition and reduced PAX3 and MITF expression, whereas no sensitization was seen in the KRAS mutant colon cancer cell line HCT116 (Figures 6B, 7A, and 7B).